Hemoglobinopathies Market Size 2019-2025: By Application ( Thalassemia, Sickle cell disease (SCD), Others), By Diagnosis ( Hemoglobin isoelectric focusing, Hemoglobin electrophoresis, High performance liquid chromatography, Genetic testing, Hemoglobin solubility test), By End-User ( Hospitals, Diagnosis laboratories, Research laboratories)

Report ID: BMRC 950 | Number of pages: 197 | Publish Date: Sep 2019 | Publisher: BMRC | Category: Lifesciences and Healthcare
Our final report will cover impact analysis of COVID-19 outbreak
Global Hemoglobinopathies Market is valued at USD 5.74 Billion in 2018 and expected to reach USD 11.08 Billion by 2025 with the CAGR of 9.85% over the forecast period. Increasing need of screening for sickle cell disease specifically in newborns is anticipated to drive the growth of Global Hemoglobinopathies Market. 

Scope of Hemoglobinopathies Market Report:

A hemoglobinopathy is an inherited blood disorder in which person has an abnormal form of hemoglobin or decreased production of hemoglobin. Globally, hemoglobinopathies is one of the most common inherited diseases and much more common in northern and central Europe including Germany due to immigration. Clear understanding of the genetics and structure of the globin chains and Hb is required during the diagnosis of hemoglobinopathies. The most common hemoglobinopathies include the sickle cell disease (SCD) and thalassemias (alpha- and beta-). Hemoglobinopathies includes a large heterogeneous group of inherited disorders of hemoglobin synthesis that can be sub classified into thalassemia syndromes and structural hemoglobin variants. Hemoglobinopathies Market report is segmented on the basis of application, diagnosis, end-user and regional & country level. Based upon application, hemoglobinopathies market is segmented into thalassemia, sickle cell disease (SCD) and others. Based upon diagnosis, hemoglobinopathies market is segmented as hemoglobin isoelectric focusing, hemoglobin electrophoresis, high performance liquid chromatography, genetic testing and hemoglobin solubility test. On the basis of end-user, the market is divided into hospitals, diagnosis laboratories and research laboratories. The regions covered in this Global Hemoglobinopathies Market report are North America, Europe, Asia-Pacific and Rest of the World. On the basis of country level, market of Global hemoglobinopathies market is sub divided into U.S., Mexico, Canada, UK, France, Germany, Italy, China, Japan, India, South East Asia, GCC, Africa, etc. Key Players for Global Hemoglobinopathies Market Report– Some major key players for Hemoglobinopathies market are Abbott Diagnostic, Bio-Rad Laboratories Inc., Danaher Corporation, Mindray Medical International Ltd., Nexcelom Bioscience LLC., Nihon Kohden Corporation, PerkinElmer Inc., Siemens Healthineers, and Sysmex Corporation and others. Increasing Cases of Sickle Cell Disorders and Thalassemia Coupled with Increasing Awareness of Healthcare is Expected to Grow the Global Hemoglobinopathies Market. The hemoglobinopathies market is expected to witness a huge demand immensely from the past few years, mainly due to the increasing cases of the sickle cell diseases (SCD), ß–thalassemia, and rising prevalence of blood related disorders among the individuals worldwide. WHO revealed that, around 7 % of the world’s population carries a hemoglobinopathy gene. In addition to this, screening and accurate identification of hemoglobin (Hb) variants have become extremely important in early days to carry out antenatal diagnosis and prevention of Hb disorders by the hemoglobinopathies. According to world health organization (WHO) reported that, nearly 5% of the world population is found with genetic hemoglobin (Hb) disorders and every year more than 42 million carriers and over 12,000 infants’ major and clinically significant hemoglobinopathy. Furthermore, new therapeutic approaches supported by favorable government initiatives from the emerging countries are fostering the growth of global hemoglobinopathies market. However, this approach is specifically required the unidirectional flow, proper training and relatively high cost can turn out to be restraining factor of this market Geographically, this report split global into several key Regions, revenue (Million USD) The geography (North America, Europe, Asia-Pacific, Latin America and Middle East & Africa) focusing on key countries in each region. It also covers market drivers, restraints, opportunities, challenges, and key issues in Global Hemoglobinopathies Market. Key Benefits for Hemoglobinopathies Market Reports • Global market report covers in-depth historical and forecast analysis. • Global market research report provides detail information about Market Introduction, Market Summary, Global market Revenue (Revenue USD), Market Drivers, Market Restraints, Market Opportunities, Competitive Analysis, Regional and Country Level. • Global market report helps to identify opportunities in market place. • Global market report covers extensive analysis of emerging trends and competitive landscape.

Global Hemoglobinopathies Market Segmentation:–

By Application: • Thalassemia • Sickle cell disease (SCD) • Others By Diagnosis • Hemoglobin isoelectric focusing • Hemoglobin electrophoresis • High performance liquid chromatography • Genetic testing • Hemoglobin solubility test By End-User: • Hospitals • Diagnosis laboratories • Research laboratories By Region • North America o U.S. o Canada o Mexico • Europe o UK o France o Germany o Russia o Rest of Europe • Asia-Pacific o China o South Korea o India o Japan o Rest of Asia-Pacific • LAMEA o Latin America o Middle East o Africa North America is Expected to Dominating the Global Hemoglobinopathies Market. North America is anticipated to dominate the hemoglobinopathies market during the forecast period. Increased immigration of high risk population along with the improved treatment and widespread presence of healthcare infrastructure has contributed to the vast implementation of newborn screening programs in this region. Nearly 70,000 to 100,000 Americans have sickle cell disease. The evolvement of non-sickling disorders, such as ß thalassemia and Hb H disease varies across the US is largely required the testing solutions like Hemoglobinopathies. In addition, Asia pacific is exponentially growing region due to the fact that recent advancements in therapeutic approaches attaining the huge interest coupled with the rise in awareness of sickle cell diseases in this region. Hemoglobinopathies Market Key Players: • Abbott Diagnostic • Bio-Rad Laboratories Inc. • Danaher Corporation • Mindray Medical International Ltd. • Nexcelom Bioscience LLC. • Nihon Kohden Corporation • PerkinElmer Inc. • Siemens Healthineers • Sysmex Corporation • others This comprehensive report will provide: • Enhance your strategic decision making • Assist with your research, presentations and business plans • Show which emerging market opportunities to focus on • Increase your industry knowledge • Keep you up-to-date with crucial market developments • Allow you to develop informed growth strategies • Build your technical insight • Illustrate trends to exploit • Strengthen your analysis of competitors • Provide risk analysis, helping you avoid the pitfalls other companies could make • Ultimately, help you to maximize profitability for your company. Our Market Research Solution Provides You Answer to Below Mentioned Question: • Which are the driving factors responsible for the growth of market? • Which are the roadblock factors of this market? • What are the new opportunities, by which market will grow in coming years? • What are the trends of this market? • Which are main factors responsible for new product launch? • How big is the global & regional market in terms of revenue, sales and production? • How far will the market grow in forecast period in terms of revenue, sales and production? • Which region is dominating the global market and what are the market shares of each region in the overall market in 2017? • How will each segment grow over the forecast period and how much revenue will these segment account for in 2025? • Which region has more opportunities?
Interested in this report?
Get your sample now!
Table of Content

1. Chapter - Report Methodology
1.1. Research Process 
1.2. Primary Research 
1.3. Secondary Research
1.4. Market Size Estimates
1.5. Data Triangulation
1.6. Forecast Model 
1.7. USP’s of Report 
1.8. Report Description 
2. Chapter – Global Hemoglobinopathies Market Overview: Qualitative Analysis
2.1. Market Introduction
2.2. Executive Summary 
2.3. Global Hemoglobinopathies Market Classification
2.4. Market Drivers
2.5. Market Restraints
2.6. Market Opportunity
2.7. Hemoglobinopathies Market: Trends
2.8. Porter’s Five Forces Analysis
2.8.1. Bargaining Power of Suppliers
2.8.2. Bargaining Power of Consumers
2.8.3. Threat of New Entrants
2.8.4. Threat of Substitute Product and Services
2.8.5. Competitive Rivalry within the Industry
2.9. Market Attractiveness Analysis 
2.9.1. Market Attractiveness Analysis by Segmentation 
2.9.2. Market Attractiveness Analysis by Region 
3. Chapter - Global Hemoglobinopathies Market Overview: Quantitative Analysis
3.1. Global Hemoglobinopathies Market Revenue (USD Million), Market Share (%) and Growth Rate (%), 2014- 2025
3.2. Global Hemoglobinopathies Market Revenue Market Share (%), 2014- 2025
3.3. Global Hemoglobinopathies Market Sales (Number of Units), Market Share (%) and Growth Rate (%), 2014- 2025
3.4. Global Hemoglobinopathies Market Sales Market Share (%), 2014- 2025
4. Chapter – Global Hemoglobinopathies Market Analysis: By Application
5. Chapter – Global Hemoglobinopathies Market Analysis: By Diagnosis
6. Chapter – Global Hemoglobinopathies Market Analysis: By End-User
7. Chapter - Global Hemoglobinopathies Market Analysis: By Manufacturer
7.1. Global Hemoglobinopathies Market Revenue (USD Million), by Manufacturer, 2014 - 2025
7.2. Global Hemoglobinopathies Market Share (%), by Manufacturer, 2018
7.3. Global Hemoglobinopathies Market Sales (Number of Units), by Manufacturer, 2014 - 2025
7.4. Global Hemoglobinopathies Market Share (%), by Manufacturer, 2018
7.5. Global Hemoglobinopathies Market Price (USD/Unit), by Manufacturer, 2014 - 2025
7.6. Global Hemoglobinopathies Market Revenue Growth Rate (%), by Manufacturer, 2014 – 2025
7.7. Merger & Acquisition
7.8. Collaborations and Partnership
7.9. New Product Launch
8. Chapter –Hemoglobinopathies Market: Regional Analysis
8.1. North America
8.1.1. North America Hemoglobinopathies Market Revenue (USD Million) and Growth Rate (%), 2014 – 2025.
8.1.2. North America Hemoglobinopathies Market Revenue (USD Million) By Country, 2014 – 2025.
8.1.3. North America Hemoglobinopathies Revenue Market Share (%) By Country, 2014 – 2025.
8.1.4. North America Hemoglobinopathies Market Revenue (USD Million) and Growth Rate, By Market Segmentation, 2014 – 2025.
8.1.5. North America Hemoglobinopathies Market Revenue (USD Million), Market Share (%) and Growth Rate, By Market Segmentation, 2014 – 2025.
8.1.6. North America Hemoglobinopathies Market Sales (Number of Units) and Growth Rate (%), 2014 – 2025.
8.1.7. North America Hemoglobinopathies Market Sales (Number of Units) By Country, 2014 – 2025.
8.1.8. North America Hemoglobinopathies Sales Market Share (%) By Country, 2014 – 2025.
8.1.9. North America Hemoglobinopathies Market Sales (Number of Units) and Growth Rate, By Market Segmentation, 2014 – 2025.
8.1.10. North America Hemoglobinopathies Market Sales (Number of Units), Market Share (%) and Growth Rate, By Market Segmentation, 2014 – 2025.
8.2. Europe
8.3. Asia Pacific
8.4. Latin America
8.5. Middle East & Africa
9. Chapter - Company Profiles
9.1. Abbott Diagnostic
9.2. Fluke Calibration
9.2.1. Financials
9.2.2. Product portfolio
9.2.3. Hemoglobinopathies Market Revenue (USD Million) and Market Share (%), 2014 - 2018
9.2.4. Hemoglobinopathies Sales Market Share (%), 2014 - 2018
9.2.5. Business strategy
9.2.6. Recent developments
9.3. Abbott Diagnostic
9.4. Bio-Rad Laboratories Inc.
9.5. Danaher Corporation
9.6. Mindray Medical International Ltd.
9.7. Nexcelom Bioscience LLC.
9.8. Nihon Kohden Corporation
9.9. PerkinElmer Inc.
9.10. Siemens Healthineers
9.11. Sysmex Corporation
9.12. others
10. Chapter – Market Research and Findings

This free Sample Report is purely a representation of our full report, for evaluating the market scope/data and make informed purchase decisions.